Antivirals for influenza: Where now for clinical practice and pandemic preparedness?

The Lancet

Volumn 384, Issue 9941, 2014, Pages 386-387

  Nguyen Van Tam, Jonathan S ^a   Openshaw, Peter J M ^b   Nicholson, Karl G ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; OSELTAMIVIR; SIALIDASE INHIBITOR; ZANAMIVIR;

2009 H1N1 INFLUENZA; CLINICAL PRACTICE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; HUMAN; INFLUENZA; MORBIDITY; MORTALITY; NOTE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROFESSIONAL STANDARD; SEASONAL INFLUENZA; DRUG EFFICACY; HOSPITAL PATIENT; INFLUENZA A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H7N9; INTENSIVE CARE UNIT; META ANALYSIS (TOPIC); NONHUMAN; OBSERVATIONAL STUDY; PANDEMIC; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC);

ANTIVIRAL AGENTS; CHILD; HUMANS; INFLUENZA, HUMAN; NEURAMINIDASE; OSELTAMIVIR; PANDEMICS; ZANAMIVIR;

EID: 84906057785     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60726-1     Document Type: Note

References (15)

1. T Jefferson, MA Jones, P Doshi et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children (Review) Cochrane Database Syst Rev 4 2014 CD008965.
2. T Jefferson, V Demicheli, J Deeks, D Rivetti Neuraminidase inhibitors for preventing and treating influenza in healthy adults Cochrane Database Syst Rev 2 2000 CD001265.
3. SG Muthuri, S Venkatesan, PR Myles et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-Analysis of individual participant data Lancet Respir Med 2014 10.1016/S2213-2600(14)70041-4 published online March 19.
4. J Hsu, N Santesso, R Mustafa et al. Antivirals for treatment of influenza: a systematic review and meta-Analysis of observational studies Ann Intern Med 156 2012 512 524
5. JK Louie, S Yang, M Acosta et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09 Clin Infect Dis 55 2012 1198 1204
6. H Yu, Z Feng, TM Uyeki et al. Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China Clin Infect Dis 52 2011 457 465
7. W Adisasmito, PK Chan, N Lee et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a global patient registry J Infect Dis 202 2010 1154 1160
8. JK Louie, S Yang, MC Samuel, TM Uyeki, R Schechter Neuraminidase inhibitors for critically ill children with influenza Pediatrics 132 2013 e1539 e1545
9. FS Dawood, AD Iuliano, C Reed et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study Lancet Infect Dis 12 2012 687 695
10. L Simonsen, P Spreeuwenberg, R Lustig et al. Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study PLoS Med 10 2013 e1001558
11. AC Hayward, EB Fragaszy, A Bermingham et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study Lancet Respir Med 2014 10.1016/S2213-2600(14)70034-7 published online March 17.
12. T Welte, A Torres, D Nathwani Clinical and economic burden of community-Acquired pneumonia among adults in Europe Thorax 67 2012 71 79
13. National Institute for Health and Care Excellence Amantadine, oseltamivir and zanamivir for the treatment of influenza. NICE technology appraisal guidance 168 http://www.nice.org.uk/nicemedia/live/11774/43268/43268.pdf 2009 (accessed May 9, 2014).
14. Centers for Disease Control and Prevention Influenza antiviral medications: summary for clinicians (current for the 2013-14 influenza season) http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm 2014 (accessed May 7, 2014).
15. Infectious Disease Society of America Statement by the Infectious Disease Society of America (IDSA) on the recent publication on "Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children" http://www.idsociety.org/Influenza-Statement.aspx April, 2014 (accessed May 7, 2014).